Patents by Inventor Scott Andrew Bockelman

Scott Andrew Bockelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Framework for modeling a clinical trial study using a cross-over treatment design
    Patent number: 10373709
    Abstract: The present disclosure provides for modeling a clinical trial study, which may implement a cross-over design. A plurality of treatments is generated for a clinical trial study, based on a first subset of operational parameters. A plurality of sequences is also generated for the clinical trial study, based on a second subset of the operational parameters. Each sequence of the plurality of sequences comprises a combination of ones of the plurality of treatments. A plurality of subject groups is assigned to the plurality of sequences, where one subject group of the plurality of subject groups is respectively assigned to one sequence of the plurality of sequences. The one sequence is administered to subjects of the one subject group during the clinical trial study.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: August 6, 2019
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Scott Andrew Bockelman, John Caron, Naresh Baliga, Leyla Badakhshanian
  • Framework for Modeling a Clinical Trial Study Using a Cross-Over Treatment Design
    Publication number: 20140330572
    Abstract: The present disclosure provides for modeling a clinical trial study, which may implement a cross-over design. A plurality of treatments is generated for a clinical trial study, based on a first subset of operational parameters. A plurality of sequences is also generated for the clinical trial study, based on a second subset of the operational parameters. Each sequence of the plurality of sequences comprises a combination of ones of the plurality of treatments. A plurality of subject groups is assigned to the plurality of sequences, where one subject group of the plurality of subject groups is respectively assigned to one sequence of the plurality of sequences. The one sequence is administered to subjects of the one subject group during the clinical trial study.
    Type: Application
    Filed: May 2, 2013
    Publication date: November 6, 2014
    Applicant: Oracle International Corporation
    Inventors: Scott Andrew Bockelman, John Caron, Naresh Baliga, Leyla Badakhshanian